Effects of the Anti-CD20 Antibody Rituximab on B Cells in Human Secondary Lymphoid Organs

被引：0
|
作者：
Kamburova, E. [1 ]
Borgman, K. [1 ]
Hans, K. [1 ]
ten Berge, I [2 ]
Joosten, I [1 ]
Hilbrands, L. [3 ]
机构：
[1] Radboud Univ Nijmegen, Med Ctr, Lab Med, Lab Med Immunol, Nijmegen, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Nephrol, Amsterdam, Netherlands
[3] Radboud Univ Nijmegen, Med Ctr, Nephrol, Nijmegen, Netherlands
来源：
TRANSPLANTATION | 2012年 / 94卷 / 10期
关键词：
D O I：
10.1097/00007890-201211271-00310
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
929
引用
收藏
页码：167 / 167
页数：1
相关论文
共 50 条
  • [41] Idiopathic membranous nephropathy (IMN) treatment with anti-CD20 monoclonal antibody Rituximab
    Lionaki, Sofia
    Sfikakis, Petros
    Theodoropoulou, Eleni
    Skalioti, Chrisanthi
    Iniotaki, Aliki
    Nakopoulou, Lydia
    Boletis, Ioannis
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 334 - 335
  • [42] Effective Treatment of Refractory Pulmonary Hemorrhage with Monoclonal Anti-CD20 Antibody (Rituximab)
    Fernando Pinto, Luis
    Candia, Liliana
    Garcia, Patricia
    Ignacio Marin, Juan
    Pachon, Ines
    Espinoza, Luis R.
    Marquez, Javier
    RESPIRATION, 2009, 78 (01) : 106 - 109
  • [43] Rituximab, a chimaeric anti-CD20 monoclonal antibody, in the treatment of hairy cell leukaemia
    Hagberg, H
    Lundholm, L
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 115 (03) : 609 - 611
  • [44] Treatment of chronic lymphocytic leukemia (CLL)with the anti-CD20 antibody rituximab.
    Emmerich, B
    Huhn, D
    Peschel, C
    Wilhelm, M
    von Schilling, C
    Bentz, M
    Hallek, M
    Knauf, B
    Kuse, R
    Ho, AD
    BLOOD, 1999, 94 (10) : 309B - 309B
  • [45] Response of pemphigus vulgaris to anti-CD20 antibody therapy (rituximab) may be delayed
    Belgi, AS
    Azeez, M
    Hoyle, C
    Williams, REA
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2006, 31 (01) : 143 - 143
  • [46] The Anti-CD20 Antibody Rituximab Reduces the Th17 Cell Response
    van de Veerdonk, Frank L.
    Lauwerys, Bernard
    Marijnissen, Renoud J.
    Timmermans, Kim
    Di Padova, Franco
    Koenders, Marije I.
    Gutierrez-Roelens, Ilse
    Durez, Patrick
    Netea, Mihai G.
    van der Meer, Jos W. M.
    van den Berg, Wim B.
    Joosten, Leo A. B.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (06): : 1507 - 1516
  • [47] Rituximab: An anti-CD20 antibody for the treatment of chronic refractory immune thrombocytopenic purpura
    Aggarwal, A
    Catlett, JP
    SOUTHERN MEDICAL JOURNAL, 2002, 95 (10) : 1209 - 1212
  • [48] Anti-CD20 antibody (Rituximab) therapy in a myasthenia gravis patient with follicular lymphoma
    Kazutaka Takagi
    Akira Yoshida
    Hiromichi Iwasaki
    Hitoshi Inoue
    Takanori Ueda
    Annals of Hematology, 2005, 84 : 548 - 550
  • [49] Anti-CD20 antibody (Rituximab) therapy in a myasthenia gravis patient with follicular lymphoma
    Takagi, K
    Yoshida, A
    Iwasaki, H
    Inoue, H
    Ueda, T
    ANNALS OF HEMATOLOGY, 2005, 84 (08) : 548 - 550
  • [50] B cell populations in the myasthenia thymus that bind Rituximab (anti-CD20)
    Zainudeen, Z.
    Attfield, K.
    Willcox, N.
    Vincent, A.
    IMMUNOLOGY, 2014, 143 : 186 - 186
12345